Mar 14, 2014 / Reports March 2014 Report to the Congress: Medicare Payment Policy Research Areas: Ambulatory Care Settings, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans
Mar 10, 2014 / Fact Sheets Fact sheet on MedPAC’s March 2014 Report to the Congress: Medicare Payment Policy Research Areas: Ambulatory Care Settings, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans
Mar 01, 2014 / Chapters Chapter 14: Status report on Part D (March 2014 report) Research Areas: Drugs, Devices, and Tests, Medicare Spending and Financing, Quality
Mar 01, 2014 / Chapters Chapter 14 online-only appendixes: Status report on Part D (March 2014 report) Research Areas: Drugs, Devices, and Tests, Medicare Spending and Financing, Quality
Feb 28, 2014 / Comment Letters MedPAC comment on contract year 2015 policy and technical changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs Research Areas: Drugs, Devices, and Tests, Private Plans
Jan 24, 2014 / Presentations Status report on Part D Research Areas: Drugs, Devices, and Tests, Private Plans
Sep 13, 2013 / Presentations Part D exceptions and appeals Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests, Private Plans
Sep 13, 2013 / Transcripts September 2013 meeting transcript Research Areas: Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Medicare Spending and Financing, Private Plans
Jun 14, 2013 / Press Releases MedPAC releases June 2013 Report to the Congress: Medicare and the Health Care Delivery System Research Areas: Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality
Mar 29, 2013 / Comment Letters MedPAC comment on CMS’s Advance Notice of Methodological Changes for Calendar Year (CY) 2014 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2014 Call Letter Research Areas: Drugs, Devices, and Tests, Private Plans